Skip to content

A randomized controlled trial of 'Machixian Jianpi Fang' in the treatment of spleen-stomach damp-heat syndrome of diarrhea type irritable bowel syndrome

A randomized controlled trial of 'Machixian Jianpi Fang' in the treatment of spleen-stomach damp-heat syndrome of diarrhea type irritable bowel syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16009764
Enrollment
Unknown
Registered
2016-11-07
Start date
2016-11-03
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diarrhea type irritable bowel syndrome

Interventions

MachixianJianpiFang group:Chinese medicinal decotion of MachixianJianpiFang
Gegenqinlian modified decoction group:Gegenqinlian modified decoction

Sponsors

Department of Traditional Chinese Medicine, Changhai hospital, The Second Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years; 2. In line with Western medicine diagnostic criteria of IBS-D; 3. In line with Chinese medicine diagnostic criteria of spleen-stomach damp-heat syndrome; 4. Baseline IBS-SSS score>75; 5. Participants or legal representatives informed,and freely give informed consent.

Exclusion criteria

Exclusion criteria: 1. Taking part in other clinical trials; 2. Having organic lesion with digestive system or systemic disease that can influence the motility of digestive tract.For example,hyperthyroidism,diabetes and chronic renal insufficiency; 3. Be combined with serious primary diseases of liver, kidney, hematopoietic system, heart and cerebral vessels.Or seriously affect their survival.For example,HIV and malignant tumors; 4. With a history of abdominal surgery(For example,cholecystectomy); 5. With nervous system diseases and a history of mental trouble; 6. To participate in the test have taken or need to continue with drug that may be affect gastrointestinal function within 2 weeks before(For example,anticholinergics,calcium antagonists,receptor antagonists of 5-HT3,obstruents,antacids,prokinetics,antidepressants,antianxietics and intestinal flora regulators); 7. Pregnant or lactating women; 8. With allergy history of drug which is used in this research.

Design outcomes

Primary

MeasureTime frame
Irritable bowel syndrome symptom severity score;Irritable bowel syndrome-quality of life questionnaire;

Countries

China

Contacts

Public ContactPeng Hao

Department of Traditional Chinese Medicine, Changhai hospital, The Second Military Medical University

ncxq19811031@163.com+86 13162465103

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026